Key result
Cardiac implantable electronic device (CIED) infections are a growing complication with significant morbidity and mortality, though their true incidence remains difficult to quantify.
CIED infections represent a growing clinical challenge with significant morbidity and mortality, complicated by difficulties in determining true incidence rates.
Answers are grounded in this paper and cite their sources.
CIED infections require heightened clinical vigilance; leaves open precise incidence estimates for standardized prospective tracking.
The indications for cardiac implantable electronic devices (CIEDs) have increased significantly over the last two decades. This has led to a surge in device implants in an expanding cohort of recipients who are in general older and who have more comorbidities. Implantation of CIED is carried out under sterile techniques and with the use of perioperative antibiotics; however, despite all these preventive measures, CIED infection remains a significant complication. Many recent reports and data from national registries have suggested an increased rate of CIED infection. However, our understanding of its true incidence remains limited due to the lack of a clear denominator as the number of patients living with CIEDs continues to expand and the pool of patients who are at risk for developing infection is growing. The importance of CIED infection has been emphasized in many recent studies that have also suggested significant morbidity and mortality risk associated with this complication that spans beyond the extraction procedure of the infected device.
No takes yet. Share an insight, caveat, or question.
Tarakji et al. (2013) conducted a review in Cardiac implantable electronic device (CIED) infections. Cardiac implantable electronic device (CIED) infections are a growing complication with significant morbidity and mortality, though their true incidence remains difficult to quantify.
Synapse has enriched 10 related papers. Consider them for comparative context: